Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
European Journal of Medical Research
Published in: European Journal of Medical Research 1/2023

Open Access 01-12-2023 | Transesophageal Echocardiography | Review

Percutaneous closure of simple congenital heart diseases under echocardiographic guidance

Authors: Ying Jiang, Fanyan Luo, Haisong Bu

Published in: European Journal of Medical Research | Issue 1/2023

Login to get access

Abstract

Congenital heart disease (CHD), birth defect with the highest incidence rates worldwide, and is mainly characterized by the abnormal internal structure of the heart or/and the anatomical structure of great vessels. In the past few decades, CHD repair surgery through standard median sternotomy incision combined with cardiopulmonary bypass (CPB) technology has been considered the gold standard for surgical correction of heart and great vessels. With the promotion and clinical application of interventional catheterization technology, transcatheter closure of CHD under radioactive radiation has gradually been recognized and applied. However, its radiation exposure and potential complications related to arteriovenous vessels still face challenges. In recent years, an increasing number of surgeons have explored new surgical procedures, for the safe and effective treatment of CHD, as far as possible to reduce surgical trauma, avoid radiation exposure, and improve the cosmetic effect. Therefore, on the premise of satisfactory exposure or guidance, how to integrate ultrasound and percutaneous interventional technology remained the focus of the exploration. This mini-review highlights and summarizes the signs of progress of ultrasound intervention in the last decade that have proven the effectiveness and operability of a well-established procedure for percutaneous closure of congenital heart diseases under echocardiographic guidance only. We discuss potential diseases that will benefit from this emerging procedure based on this progress. Owing to the crucial advantages played by this strategy in the treatment of CHD, better understanding and promotion of this less exploited field may contribute to the development of therapeutics targeting CHD, improve medical utilization rate, promote the optimization of medical resources, and ultimately achieve precise and efficient medical treatment.
Literature
1.
Mustacchi P, Sherins RS, Miller MJ. Congenital malformations of the heart and the great vessels. Prevalence, incidence, and life expectancy in San Francisco. JAMA. 1963;183:241–4.PubMedCrossRef
2.
Bu H, Liu L, Hu S, Tan Z, Zhao T. Targeted next-generation sequencing for research and diagnostics in congenital heart disease, and cleft lip and/or palate. Mol Med Rep. 2019;19(5):3831–40.PubMed
3.
Hu S, Yang Y, Zhu Y, Wu Q, Muhoozi R, Wei S, et al. Experience with percardiac interventions for multiple congenital heart diseases in children. Interact Cardiovasc Thorac Surg. 2014;19(5):812–5.PubMedCrossRef
4.
Rein JG, Freed MD, Norwood WI, Castaneda AR. Early and late results of closure of ventricular septal defect in infancy. Ann Thorac Surg. 1977;24(1):19–27.PubMedCrossRef
5.
Butera G, Carminati M, Chessa M, Piazza L, Micheletti A, Negura DG, et al. Transcatheter closure of perimembranous ventricular septal defects: early and long-term results. J Am Coll Cardiol. 2007;50(12):1189–95.PubMedCrossRef
6.
Carminati M, Butera G, Chessa M, De Giovanni J, Fisher G, Gewillig M, et al. Transcatheter closure of congenital ventricular septal defects: results of the European Registry. Eur Heart J. 2007;28(19):2361–8.PubMedCrossRef
7.
8.
Opotowsky AR, Landzberg MJ, Kimmel SE, Webb GD. Trends in the use of percutaneous closure of patent foramen ovale and atrial septal defect in adults, 1998–2004. JAMA. 2008;299(5):521–2.PubMedCrossRef
9.
Baruteau AE, Hascoet S, Baruteau J, Boudjemline Y, Lambert V, Angel CY, et al. Transcatheter closure of patent ductus arteriosus: past, present and future. Arch Cardiovasc Dis. 2014;107(2):122–32.PubMedCrossRef
10.
Omelchenko A, Gorbatykh Y, Voitov A, Zaitsev G, Bogachev-Prokophiev A, Karaskov A. Perventricular device closure of ventricular septal defects: results in patients less than 1 year of age. Interact Cardiovasc Thorac Surg. 2016;22(1):53–6.PubMedCrossRef
11.
Zeng XJ, Sun SQ, Chen XF, Ma XJ, Luo YH, Lim YP, et al. Device closure of perimembranous ventricular septal defects with a minimally invasive technique in 12 patients. Ann Thorac Surg. 2008;85(1):192–4.PubMedCrossRef
12.
Bacha E. New procedures, new complications, and new strategies to deal with them. J Thorac Cardiovasc Surg. 2015;149(2):531.PubMedCrossRef
13.
Hu S, Yang Y, Wu Q, Zhao T. Surgical treatment for patients with complete atrioventricular block after device closure of perimembranous ventricular septal defects. J Thorac Cardiovasc Surg. 2015;149(2):530–1.PubMedCrossRef
14.
Quansheng X, Silin P, Zhongyun Z, Youbao R, Shengde L, Qian C, et al. Minimally invasive perventricular device closure of an isolated perimembranous ventricular septal defect with a newly designed delivery system: preliminary experience. J Thorac Cardiovasc Surg. 2009;137(3):556–9.PubMedCrossRef
15.
Xing Q, Pan S, An Q, Zhang Z, Li J, Li F, et al. Minimally invasive perventricular device closure of perimembranous ventricular septal defect without cardiopulmonary bypass: multicenter experience and mid-term follow-up. J Thorac Cardiovasc Surg. 2010;139(6):1409–15.PubMedCrossRef
16.
Wu Q, Yang Y, Xu X, Gao L, Yang J, Wang X, et al. Echocardiography in mini-invasive surgical device closure of secundum atrial septal defects. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2013;38(6):602–9.PubMed
17.
You T, Yi K, Ding ZH, Hou XD, Liu XG, Wang XK, et al. Transcatheter closure, mini-invasive closure and open-heart surgical repair for treatment of perimembranous ventricular septal defects in children: a protocol for a network meta-analysis. BMJ Open. 2017;7(6): e015642.PubMedPubMedCentralCrossRef
18.
Vida VL, Padalino MA, Bhattarai A, Stellin G. Right posterior-lateral minithoracotomy access for treating congenital heart disease. Ann Thorac Surg. 2011;92(6):2278–80.PubMedCrossRef
19.
Li G, Su J, Fan X, Li Z, Zhang J, Zhu Y, et al. Safety and efficacy of ventricular septal defect repair using a cosmetic shorter right lateral thoracotomy on infants weighing less than 5 kg. Heart Lung Circ. 2015;24(9):898–904.PubMedCrossRef
20.
Zhang W, Gao L, Jin W, Wu Q, Hu S, Yang Y, et al. Echocardiography-guided percutaneous closure of patent ductus arteriosus without arterial access: feasibility and safety for a new strategy. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2018;43(9):1000–6.PubMed
21.
An G, Zhang H, Zheng S, Wang W, Wu Q, Xing Q. Minimally invasive surgical closure for doubly committed subarterial ventricular septal defects through a right subaxillary thoracotomy. Interact Cardiovasc Thorac Surg. 2016;23(6):924–8.PubMedCrossRef
22.
Yang Y, Zhang W, Wu Q, Gao L, Jin W, Zhao T. Transcatheter closure of atrial septal defects without fluoroscopy: a well-established procedure for alternative use in children. EuroIntervention. 2016;12(5):e652-657.PubMedCrossRef
23.
Bu H, Yang Y, Wu Q, Jin W, Zhao T. Echocardiography-guided percutaneous closure of perimembranous ventricular septal defects without arterial access and fluoroscopy. BMC Pediatr. 2019;19(1):302.PubMedPubMedCentralCrossRef
24.
Zamorano JL, Badano LP, Bruce C, Chan KL, Goncalves A, Hahn RT, et al. EAE/ASE recommendations for the use of echocardiography in new transcatheter interventions for valvular heart disease. J Am Soc Echocardiogr. 2011;24(9):937–65.PubMedCrossRef
25.
Silvestry FE, Cohen MS, Armsby LB, Burkule NJ, Fleishman CE, Hijazi ZM, et al. Guidelines for the echocardiographic assessment of atrial septal defect and patent foramen ovale: from the American Society of Echocardiography and Society for Cardiac Angiography and Interventions. J Am Soc Echocardiogr. 2015;28(8):910–58.PubMedCrossRef
26.
Biner S, Perk G, Kar S, Rafique AM, Slater J, Shiota T, et al. Utility of combined two-dimensional and three-dimensional transesophageal imaging for catheter-based mitral valve clip repair of mitral regurgitation. J Am Soc Echocardiogr. 2011;24(6):611–7.PubMedCrossRef
27.
Kent DM, Dahabreh IJ, Ruthazer R, Furlan AJ, Reisman M, Carroll JD, et al. Device closure of patent foramen ovale after stroke: pooled analysis of completed randomized trials. J Am Coll Cardiol. 2016;67(8):907–17.PubMedPubMedCentralCrossRef
28.
Rayhill M, Burch R. PFO and migraine: is there a role for closure? Curr Neurol Neurosci Rep. 2017;17(3):20.PubMedCrossRef
29.
Meissner I, Khandheria BK, Heit JA, Petty GW, Sheps SG, Schwartz GL, et al. Patent foramen ovale: innocent or guilty? Evidence from a prospective population-based study. J Am Coll Cardiol. 2006;47(2):440–5.PubMedCrossRef
30.
Hara H, Virmani R, Ladich E, Mackey-Bojack S, Titus J, Reisman M, et al. Patent foramen ovale: current pathology, pathophysiology, and clinical status. J Am Coll Cardiol. 2005;46(9):1768–76.PubMedCrossRef
31.
Di Tullio MR. Patent foramen ovale: echocardiographic detection and clinical relevance in stroke. J Am Soc Echocardiogr. 2010;23(2):144–55.PubMedCrossRef
32.
33.
Carroll JD, Saver JL, Thaler DE, Smalling RW, Berry S, MacDonald LA, et al. Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. N Engl J Med. 2013;368(12):1092–100.PubMedCrossRef
34.
Tobis JM, Charles A, Silberstein SD, Sorensen S, Maini B, Horwitz PA, et al. Percutaneous closure of patent foramen ovale in patients with migraine: the PREMIUM trial. J Am Coll Cardiol. 2017;70(22):2766–74.PubMedCrossRef
35.
Homma S, Messe SR, Rundek T, Sun YP, Franke J, Davidson K, et al. Patent foramen ovale. Nat Rev Dis Primers. 2016;2:15086.PubMedCrossRef
36.
Fateh-Moghadam S, Steeg M, Dietz R, Bocksch W. Is routine ultrasound guidance really necessary for closure of patent foramen ovale using the Amplatzer PFO occluder? Catheter Cardiovasc Interv. 2009;73(3):361–6.PubMedCrossRef
37.
Mangieri A, Godino C, Montorfano M, Arioli F, Rosa I, Ajello S, et al. PFO closure with only fluoroscopic guidance: 7 years real-world single centre experience. Catheter Cardiovasc Interv. 2015;86(1):105–12.PubMedCrossRef
38.
Meier B, Kalesan B, Mattle HP, Khattab AA, Hildick-Smith D, Dudek D, et al. Percutaneous closure of patent foramen ovale in cryptogenic embolism. N Engl J Med. 2013;368(12):1083–91.PubMedCrossRef
39.
Scacciatella P, Meynet I, Giorgi M, Biava LM, Matranga I, Biasco L, et al. Angiography vs transesophageal echocardiography-guided patent foramen ovale closure: a propensity score matched analysis of a two-center registry. Echocardiography. 2018;35(6):834–40.PubMedCrossRef
40.
Sperlongano S, Giordano M, Ciccarelli G, Bassi G, Malvezzi Caracciolo D’Aquino M, Del Giudice C, et al. Advances in percutaneous patent foramen ovale closure: from the procedure to the echocardiographic guidance. J Clin Med. 2022;11(14):4001.PubMedPubMedCentralCrossRef
41.
42.
Lan Q, Wu F, Ye X, Wang S, Zhong J. Intracardiac vs. transesophageal echocardiography for guiding transcatheter closure of interatrial communications: a systematic review and meta-analysis. Front Cardiovasc Med. 2023;10:1082663.PubMedPubMedCentralCrossRef
43.
Achim A, Hochegger P, Kanoun Schnur SS, Moser L, Stark C, Pranevicius R, et al. Transesophageal echocardiography-guided versus fluoroscopy-guided patent foramen ovale closure: a single center registry. Echocardiography. 2023;40(7):657–63.PubMedCrossRef
44.
King TD, Thompson SL, Steiner C, Mills NL. Secundum atrial septal defect. Nonoperative closure during cardiac catheterization. JAMA. 1976;235(23):2506–9.PubMedCrossRef
45.
Everett AD, Jennings J, Sibinga E, Owada C, Lim DS, Cheatham J, et al. Community use of the amplatzer atrial septal defect occluder: results of the multicenter MAGIC atrial septal defect study. Pediatr Cardiol. 2009;30(3):240–7.PubMedCrossRef
46.
Jones TK, Latson LA, Zahn E, Fleishman CE, Jacobson J, Vincent R, et al. Results of the U.S. multicenter pivotal study of the HELEX septal occluder for percutaneous closure of secundum atrial septal defects. J Am Coll Cardiol. 2007;49(22):2215–21.PubMedCrossRef
47.
Moore J, Hegde S, El-Said H, Beekman R 3rd, Benson L, Bergersen L, et al. Transcatheter device closure of atrial septal defects: a safety review. JACC Cardiovasc Interv. 2013;6(5):433–42.PubMedCrossRef
48.
Johnson JN, Hornik CP, Li JS, Benjamin DK Jr, Yoshizumi TT, Reiman RE, et al. Cumulative radiation exposure and cancer risk estimation in children with heart disease. Circulation. 2014;130(2):161–7.PubMedPubMedCentralCrossRef
49.
Andreassi MG, Ait-Ali L, Botto N, Manfredi S, Mottola G, Picano E. Cardiac catheterization and long-term chromosomal damage in children with congenital heart disease. Eur Heart J. 2006;27(22):2703–8.PubMedCrossRef
50.
Allen HD, Driscoll DJ, Fricker FJ, Herndon P, Mullins CE, Snider AR, et al. Guidelines for pediatric therapeutic cardiac catheterization. A statement for health professionals from the Committee on Congenital Cardiac Defects of the Council on Cardiovascular Disease in the Young, the American Heart Association. Circulation. 1991;84(5):2248–58.PubMedCrossRef
51.
Bacher K, Bogaert E, Lapere R, De Wolf D, Thierens H. Patient-specific dose and radiation risk estimation in pediatric cardiac catheterization. Circulation. 2005;111(1):83–9.PubMedCrossRef
52.
Ewert P, Daehnert I, Berger F, Kaestner A, Krings G, Vogel M, et al. Transcatheter closure of atrial septal defects under echocardiographic guidance without X-ray: initial experiences. Cardiol Young. 1999;9(2):136–40.PubMedCrossRef
53.
Ewert P, Berger F, Daehnert I, van Wees J, Gittermann M, Abdul-Khaliq H, et al. Transcatheter closure of atrial septal defects without fluoroscopy: feasibility of a new method. Circulation. 2000;101(8):847–9.PubMedCrossRef
54.
Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002;39(12):1890–900.PubMedCrossRef
55.
Holzer R, Balzer D, Cao QL, Lock K, Hijazi ZM. Amplatzer muscular ventricular septal defect I: device closure of muscular ventricular septal defects using the amplatzer muscular ventricular septal defect occluder: immediate and mid-term results of a U.S. registry. J Am Coll Cardiol. 2004;43(7):1257–63.PubMedCrossRef
56.
Qin Y, Chen J, Zhao X, Liao D, Mu R, Wang S, et al. Transcatheter closure of perimembranous ventricular septal defect using a modified double-disk occluder. Am J Cardiol. 2008;101(12):1781–6.PubMedCrossRef
57.
Gu M, You X, Zhao X, Zheng X, Qin YW. Transcatheter device closure of intracristal ventricular septal defects. Am J Cardiol. 2011;107(1):110–3.PubMedCrossRef
58.
Hu S, Yang Y, Wu Q, Rwakaryebe M, Liu Z, Deng Y, et al. Results of two different approaches to closure of subaortic ventricular septal defects in children. Eur J Cardiothorac Surg. 2014;46(4):648–53.PubMedCrossRef
59.
Wang S, Ouyang W, Liu Y, Zhang F, Guo G, Zhao G, et al. Transcatheter perimembranous ventricular septal defect closure under transthoracic echocardiographic guidance without fluoroscopy. J Thorac Dis. 2018;10(9):5222–31.PubMedPubMedCentralCrossRef
60.
Dodge-Khatami A, Knirsch W, Tomaske M, Pretre R, Bettex D, Rousson V, et al. Spontaneous closure of small residual ventricular septal defects after surgical repair. Ann Thorac Surg. 2007;83(3):902–5.PubMedCrossRef
61.
Gabriel HM, Heger M, Innerhofer P, Zehetgruber M, Mundigler G, Wimmer M, et al. Long-term outcome of patients with ventricular septal defect considered not to require surgical closure during childhood. J Am Coll Cardiol. 2002;39(6):1066–71.PubMedCrossRef
62.
Momma K, Toyama K, Takao A, Ando M, Nakazawa M, Hirosawa K, et al. Natural history of subarterial infundibular ventricular septal defect. Am Heart J. 1984;108(5):1312–7.PubMedCrossRef
63.
Bu H, Yang Y, Wu Q, Zhao T. Percutaneous puncture closure of postoperative residual ventricular septal defects without radiation. Ann Thorac Surg. 2020;109(6):e457–9.PubMedCrossRef
64.
Mo X, Qi J, Zuo W. Percutaneous punctured transcatheter device closure of residual shunt after ventricular septal defect repair. Case Rep Cardiol. 2016;2016:8124731.PubMedPubMedCentral
65.
Thanopoulos BD, Hakim FA, Hiari A, Goussous Y, Basta E, Zarayelyan AA, et al. Further experience with transcatheter closure of the patent ductus arteriosus using the Amplatzer duct occluder. J Am Coll Cardiol. 2000;35(4):1016–21.PubMedCrossRef
66.
Pass RH, Hijazi Z, Hsu DT, Lewis V, Hellenbrand WE. Multicenter USA Amplatzer patent ductus arteriosus occlusion device trial: initial and one-year results. J Am Coll Cardiol. 2004;44(3):513–9.PubMedCrossRef
67.
Faella HJ, Hijazi ZM. Closure of the patent ductus arteriosus with the amplatzer PDA device: immediate results of the international clinical trial. Catheter Cardiovasc Interv. 2000;51(1):50–4.PubMedCrossRef
68.
Vijayalakshmi IB, Chitra N, Praveen J, Prasanna SR. Challenges in device closure of a large patent ductus arteriosus in infants weighing less than 6 kg. J Interv Cardiol. 2013;26(1):69–76.PubMedCrossRef
69.
Tanidir IC, Guzeltas A, Ergul Y, Ozturk E, Ozyilmaz I, Odemis E. Transcatheter patent ductus arteriosus closure with echocardiographic guidance: can radiation exposure be reduced? Turk Kardiyol Dern Ars. 2014;42(7):643–50.PubMedCrossRef
70.
Sivakumar K, Bhagyavathy A, Gnanapragasam F. Closure of large patent ductus arteriosus in renal failure under echocardiographic guidance without use of radiographic contrast media. Congenit Heart Dis. 2009;4(1):59–62.PubMedCrossRef
71.
Garg G, Srivastava A, Tyagi H, Reddy SP, Radha AS. Transcatheter device closure of patent ductus arteriosus without arterial access–single institution experience. Indian Heart J. 2013;65(5):546–51.PubMedPubMedCentralCrossRef
72.
Pan X, Ouyang W, Li S, Guo G, Liu Y, Zhang D, et al. Safety and efficacy of percutaneous patent ductus arteriosus closure solely under thoracic echocardiography guidance. Zhonghua Xin Xue Guan Bing Za Zhi. 2015;43(1):31–3.PubMed
73.
Rao PS. Percutaneous balloon pulmonary valvuloplasty: state of the art. Catheter Cardiovasc Interv. 2007;69(5):747–63.PubMedCrossRef
74.
Kan JS, White RI Jr, Mitchell SE, Gardner TJ. Percutaneous balloon valvuloplasty: a new method for treating congenital pulmonary-valve stenosis. N Engl J Med. 1982;307(9):540–2.PubMedCrossRef
75.
Maostafa BA, Seyed-Hossien M, Shahrokh R. Long-term results of balloon pulmonary valvuloplasty in children with congenital pulmonary valve stenosis. Iran J Pediatr. 2013;23(1):32–6.PubMed
76.
Deng RD, Zhang FW, Zhao GZ, Wen B, Wang SZ, Ou-Yang WB, et al. A novel double-balloon catheter for percutaneous balloon pulmonary valvuloplasty under echocardiographic guidance only. J Cardiol. 2020;76(3):236–43.PubMedCrossRef
77.
Patel H, Raisinghani A, DeMaria A. Echocardiography in transcatheter structural heart disease interventions. Prog Cardiovasc Dis. 2018;61(5–6):423–36.PubMedCrossRef
78.
Bu H, Gao L, Zhang W, Wu Q, Jin W, Tang M, et al. Application of perimembranous ventricular septal defects closure solely by femoral vein approach under transesophageal echocardiography guidance. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2017;42(7):802–7.PubMed
79.
Wang SZ, Ou-Yang WB, Hu SS, Pang KJ, Liu Y, Zhang FW, et al. First-in-human percutaneous balloon pulmonary valvuloplasty under echocardiographic guidance only. Congenit Heart Dis. 2016;11(6):716–20.PubMedCrossRef
80.
Holzer RJ, Gauvreau K, Kreutzer J, Trucco SM, Torres A, Shahanavaz S, et al. Safety and efficacy of balloon pulmonary valvuloplasty: a multicenter experience. Catheter Cardiovasc Interv. 2012;80(4):663–72.PubMedCrossRef
81.
Potekhin NP, Nikitin AV, Evsiukov KB, Klopotskii SA, Zaitseva EA. Progression prevention, diagnosis, and treatment of contrast agent-induced nephropathy. Voen Med Zh. 2009;330(6):27–32.PubMed
82.
Mini N, Zartner PA, Schneider MBE. Stenting of critical aortic coarctation in neonates between 600 and 1350 g. Using a transfemoral artery approach. A single center experience. Front Cardiovasc Med. 2022;9:1025411.PubMedPubMedCentralCrossRef
83.
Mini N, Zartner PA, Sabir H, Suchowerskyj P, Schneider MBE. Echocardiogram-guided stenting of a critical aortic coarctation in an extremely low weight preterm infant. JACC Case Rep. 2023;13: 101815.PubMedPubMedCentralCrossRef
84.
Dorfman AL, Fazel R, Einstein AJ, Applegate KE, Krumholz HM, Wang Y, et al. Use of medical imaging procedures with ionizing radiation in children: a population-based study. Arch Pediatr Adolesc Med. 2011;165(5):458–64.PubMedPubMedCentralCrossRef
85.
Roguin A, Goldstein J, Bar O, Goldstein JA. Brain and neck tumors among physicians performing interventional procedures. Am J Cardiol. 2013;111(9):1368–72.PubMedCrossRef
86.
Andreassi MG, Piccaluga E, Gargani L, Sabatino L, Borghini A, Faita F, et al. Subclinical carotid atherosclerosis and early vascular aging from long-term low-dose ionizing radiation exposure: a genetic, telomere, and vascular ultrasound study in cardiac catheterization laboratory staff. JACC Cardiovasc Interv. 2015;8(4):616–27.PubMedCrossRef
87.
Patrianakos AP, Zacharaki AA, Skalidis EI, Hamilos MI, Parthenakis FI, Vardas PE. The growing role of echocardiography in interventional cardiology: the present and the future. Hellenic J Cardiol. 2017;58(1):17–31.PubMedCrossRef
88.
George RS, Lozier JS, Bocks ML. Palliative stenting of the venous duct in a premature neonate with obstructed infradiaphragmatic total anomalous pulmonary venous connection. Cardiol Young. 2023;33(4):633–6.PubMedCrossRef
Metadata
Title
Percutaneous closure of simple congenital heart diseases under echocardiographic guidance
Authors
Ying Jiang
Fanyan Luo
Haisong Bu
Publication date
01-12-2023

Other articles of this Issue 1/2023

European Journal of Medical Research 1/2023 Go to the issue

Research

The global prevalence of primary central nervous system tumors: a systematic review and meta-analysis

Research

Dynamic change of the systemic immune inflammation index is a risk factor for patients with oropharyngeal cancer: a case control study and an additional HPV-status subgroup analysis

Research

Non-alcoholic fatty liver disease associated with greater herpes zoster risk than alcoholic fatty liver disease

Review

Biological effects and mechanisms of fisetin in cancer: a promising anti-cancer agent

Research

Unusual grafts for living-donor liver transplantation

Research

Exosomal NOX1 promotes tumor-associated macrophage M2 polarization-mediated cancer progression by stimulating ROS production in cervical cancer: a preliminary study